| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 10.11× | 10.11× | 11.57× | — | 23.29× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.55× | 0.55× | 0.49× | 0.40× | 0.35× | ||
| 0.96× | 0.96× | 0.93× | 0.70× | 0.81× | ||
| 0.82× | 0.82× | 0.83× | 0.78× | 0.74× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 23.29 | — | 11.57 | 10.11 | 10.11 | |
| Asset Turnover | 0.35 | 0.40 | 0.49 | 0.55 | 0.55 | |
| Cash Conversion (CFO/Net Income) | 0.81 | 0.70 | 0.93 | 0.96 | 0.96 | |
| CFO/EBITDA | 0.74 | 0.78 | 0.83 | 0.82 | 0.82 |